| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Bone Diseases, Metabolic | D001851 | 9 associated lipids |
| Adrenal Hyperplasia, Congenital | D000312 | 2 associated lipids |
| Obesity | D009765 | 29 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Femur Head Necrosis | D005271 | 5 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
| Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
| Totoson P et al. | Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. | 2016 | PLoS ONE | pmid:26761790 |
| Iezaki T et al. | The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. | 2016 | J. Bone Miner. Res. | pmid:26391411 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| Li XJ et al. | Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. | 2016 | Int. J. Mol. Med. | pmid:27840967 |
| Zhou J and Zhao Y | Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. | 2016 | Med. Sci. Monit. | pmid:27828936 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |
| Wei CC et al. | Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. | 2016 | Mediators Inflamm. | pmid:27199510 |